Transtracheal air in the treatment of obstructive sleep apnoea hypopnoea syndrome.
A 49 year old woman with typical obstructive sleep apnoea hypopnoea syndrome underwent an unsuccessful trial with continuous positive airway pressure (CPAP) followed by uvulopalatopharyngoplasty with septorhinoplasty, treatment with protriptyline, and a second CPAP trial that was abandoned. Transtracheal air was then given and normalised sleep and breathing at a flow rate of 5 l/min. A sustained clinical improvement was observed at follow up visits. Transtracheal air could represent a simple and effective alternative to tracheotomy in patients with obstructive sleep apnoea hypopnoea syndrome in whom conventional treatments fail.
Sériès
F
F
Unité de recherche, Centre de Pneumologie, Hôpital Laval, Université Laval, Québec, G1V 4G5 Canada.
Forge
J L
JL
Lampron
N
N
Cormier
Y
Y
D005260:Female; D006801:Humans; D008875:Middle Aged; D010100:Oxygen / Q000008:administration & dosage*; D020181:Sleep Apnea, Obstructive / Q000628:therapy*; D014132:Trachea; D017211:Treatment Failure
D010100:Oxygen